Israel Englander Puma Biotechnology, Inc. Call Options Transaction History

Millennium Management LLC

  • $207 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024
BUY
$4.29 - $7.4 $537,108 - $926,480
125,200 New
125,200 $663,000
Q2 2023

Aug 14, 2023
BUY
$2.6 - $3.58 $40,040 - $55,132
15,400 Added 6.2%
263,800 $931,000
Q1 2023

May 15, 2023
BUY
$2.21 - $4.82 $548,964 - $1.2 Million
248,400 New
248,400 $768,000
Q3 2022

Nov 14, 2022
BUY
$2.27 - $3.84 $496,222 - $839,424
218,600 New
218,600 $518,000

Others Institutions Holding PBYI

# of Institutions
101
Shares Held
30.4M
Call Options Held
73.5K
Put Options Held
18.5K
View Full List

About PUMA BIOTECHNOLOGY, INC.

PBYI Quotes by TradingView
  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $139M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email